Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1242 Epidemiological Characteristics from a Single Centre Database. Cohort of 1301 Neuroendocrine Tumor Patients: Is There an Association Between Age and Grade of NET?

Introduction: There is limited data related to epidemiology of NETs and patient survival. For many cancers younger age of diagnosis can be associated with worse survival.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Garcia-Hernandez J, Mohmaduvesh M, Toumpanakis C, Caplin M,

Keywords: Survival,

#1135 The Role of External Beam Radiotherapy in the Management of Advanced Neuroendocrine Tumors

Introduction: Palliative external beam radiotherapy (EBRT) is routinely used to control symptoms and disease progression in metastatic malignancies, but there is limited data in metastatic neuroendocrine tumours (NET).

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Tharmalingam H, Owen C, Walker M, Caplin M,

Keywords: EBRT, NET,

#1134 Role of Cytoreductive Surgery (CRS) and Intraoperative Hyperthermicintraperitoneal Chemotherapy (HIPEC) for High Grade Neuroendocrine Tumour

Introduction: Managing patients with omental and peritoneal Nueroendocrine tumour is challenging.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Cecil T, Eldeep H, Toumpanakis C, Caplin M,

Keywords: CRS HIPEC NET,

#1126 Long-Term Follow-Up and Survival Data in Progressing Advanced Midgut Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) is an effective treatment option for advanced Neuroendocrine Tumours (NET), however long term survival data is lacking.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Oliveira A, Pencharz D, Navalkissoor S, Quigley A,

Keywords: PRRT, PFS, OS,

#1106 Salvage Treatment with Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Advanced VIPomas and Severe Verner-Morrison Syndrome

Introduction: PRRT is an effective treatment option for advanced Neuroendocrine Tumours

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Yalchin M, Gertner J, Navalkissoor S, Quigley A, Meyer T,

Keywords: PRRT VIP,